Alchemab Is Bringing A New Meaning To Patient-Centered Care

British-Bostonian Biotech Is Working Backwards To Explain Disease Resilience

 
• By Chloe Kent

Alchemab Therapeutics sequences the antibodies of patients who prove especially resilient to hard-to-treat diseases to try and find therapeutic targets.

Depiction of an antibody
Alchemab is sequencing patients' B-cells in the hope of finding treatments for serious illnesses • Source: Shutterstock

More from Innovation

More from In Vivo